Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics of Imrecoxib in Hepatic Impairment
NCT02456688Phase 1Unknown
- Sponsor
- Hengrui
- Start
- Jan 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of imrecoxib in knee osteoarthritis (OA) (2 arms), sponsored by Hengrui. Primary endpoints: Area under the concentration time curve from 0 to infinity at 5 days, Maximum observed plasma drug concentration at 5 days and 1 more. Status: unknown.
02
Drugs
imrecoxib
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT02456688.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02456688.